Nicole Godresse has over 20 years of experience in the pharmaceutical and healthcare industry, holding senior commercial roles with major multinational companies including Eli Lilly, Johnson & Johnson, Schering-Plough, Merck Sharp & Dohme, and Tilray.
Ms Godresse is a true pioneer of medicinal cannabis in Australia, New Zealand and the broader Asia Pacific region. In her most recent roles as general manager of ANZ and director of emerging markets at Tilray, Ms Godresse was Instrumental in launching the first Medical Cannabis brand legally in Australia and New Zealand, launching one of the first Medical Cannabis clinics in Australia, delivering some of Australia's first government-funded cannabis clinical trials, negotiating major exclusive government supply agreements, and establishing a sustained market leadership position in both markets during her tenure. She also made significant inroads into Asia including negotiating the supply of CBD product imports into the region.
